Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v14-EN Version v8-FR
Language English French
Date Updated 2022-03-25 2020-11-02
Drug Identification Number 00885975 00885975
Brand name VIVOTIF VIVOTIF
Common or Proper name TYPHOID VACCINE LIVE ORAL ATTENUATED TY21A TYPHOID VACCINE LIVE ORAL ATTENUATED TY21A
Company Name BAVARIAN NORDIC AS BAVARIAN NORDIC AS
Ingredients TYPHOID VACCINE TYPHOID VACCINE
Strength(s) 10B 10B
Dosage form(s) CAPSULE (ENTERIC-COATED) CAPSULE (ENTERIC-COATED)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 4 enteric-coated capsules per blister 4 enteric-coated capsules per blister
ATC code J07AP J07AP
ATC description BACTERIAL VACCINES BACTERIAL VACCINES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-06-30 2021-06-30
Estimated end date 2022-03-22 Unknown
Actual end date 2022-03-24
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments